NCT01572675View on ClinicalTrials.gov

A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148)

CompletedOBSERVATIONAL
Enrollment

547

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions
Osteoarthritis
Interventions
DRUG

etorocoxib

Administered as 30 mg or 60 mg oral film-coated tablets

DRUG

celecoxib

Administered as 100 mg or 200 mg oral hard capsules

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT01572675 - A Study of the Patterns of Use of Etoricoxib in France (MK-0663-148) | Biotech Hunter | Biotech Hunter